TY - JOUR
TI - Sarcomas of the head and neck. Results from the treatment of 25 patients
AU - Rapidis, AD
AU - Gakiopoulou, H
AU - Stavrianos, SD
AU - Vilos, GA and
AU - Faratzis, G
AU - Douzinas, EE
AU - Givalos, N
AU - Patsouris, E
JO - EJSO
PY - 2005
VL - 31
TODO - 2
SP - 177-182
PB - Elsevier Sci Ltd, Exeter, United Kingdom
SN - null
TODO - 10.1016/j.ejso.2004.09.020
TODO - head and neck sarcomas; osteosarcoma; leiomyosarcoma; malignant fibrous
histiocytoma; chondrosarcoma; angiosarcoma; liposarcoma; fibrosarcoma
TODO - Aims. Head and neck sarcomas comprise a heterogenous and biologically
diverse group of rare neoplasms. In an effort to clarify some of the
obscure clinical. behavior of head and neck sarcomas, we present our
experience and review the relevant Literature.
Methods. Retrospective analysis of patients with histologically proven
head and neck sarcomas treated in a tertiary Hospital, Department
between 1992 and 2002.
Results. During this period, 25 patients with head and neck sarcomas
were registered. Follow-up ranged from 8 to 144 months. Twenty-three.
patients were treated with surgery as the primary modality; 14 were
treated by surgery alone. Clear margins were obtained in all. of them
and local control was achieved in 12/13. The 2-and 5-year survival rates
for the entire group were 80 and 40%, respectively. Mean overall
survival time of our patients was 62 months (median 52 months).
Conclusions. Surgical, treatment remains the cornerstone of therapeutic
management of head and neck sarcomas. (C) 2004 Elsevier Ltd. ALL rights
reserved.
ER -